Medical Journals

Aberrant Accumulation of Serotonin in Dopaminergic Neurons.

Authors:
  • Mössner Rainald
  • Simantov Rabi
  • Marx Alexander
  • Lesch Klaus Peter
  • Seif Isabelle

From: Department of Psychiatry and Psychotherapy, University of Würzburg, Füchsleinstr. 15, 97080 Würzburg, Germany. rainald.moessner@mail.uni-wuerzburg.de

Neuroscience letters

  • Publish Date: Jun 2006
  • ISSN: 0304-3940
  • Volume: 401
  • Issue: 1-2
  • Pages: 49-54
  • Medium: Print
  • Language: English
  • Citation (JAMA): Mössner Rainald, Simantov Rabi, Marx Alexander, et al. Aberrant Accumulation of Serotonin in Dopaminergic Neurons.. Neurosci. Lett. Jun 2006;401:49-54

Abstract

Gene targeting approaches greatly facilitate insight into the functioning of monoamine transporters, the targets of potent antidepressants. The serotonin transporter (5-HTT) is the molecular target of a large number of antidepressants. To assess the clearance of serotonin (5-HT) in the absence of the 5-HTT, we have generated double knockout mice lacking both the 5-HTT and the catabolizing enzyme monoamine oxidase A (MAOA). We found aberrant 5-HT accumulation in the striatum of these MAOA/5-HTT double knockout mice. By additional ablation of the dopamine transporter (DAT), this aberrant 5-HT accumulation was abolished in MAOA/5-HTT/DAT triple knockout mice. Thus, aberrant uptake of 5-HT occurs in dopaminergic terminals under conditions of elevated 5-HT levels, and this aberrant uptake is mediated by the DAT. These findings have important consequences for antidepressant therapy, since during treatment of depression with selective serotonin reuptake inhibitors, clearance of 5-HT by dopaminergic neurons may reduce the desired therapeutic elevation of extracellular 5-HT levels. This provides a molecular rationale for improving antidepressant efficacy by additional pharmacological inhibition of the DAT.

Mesh Headings (Keywords): Animals, Brain, Brain Chemistry, Depressive Disorder, Dopamine, Dopamine Plasma Membrane Transport Proteins, Female, Male, Mice, Mice, Knockout, Monoamine Oxidase, Neurons, Presynaptic Terminals, Serotonin, Serotonin Plasma Membrane Transport Proteins, Serotonin Uptake Inhibitors, Up-Regulation


Check for Full Text / PubMed Unique Identifier (PMID): 16638624


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.